SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-046210
Filing Date
2024-11-12
Accepted
2024-11-12 16:41:13
Documents
4
Period of Report
2024-12-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20036455x2_def14a.htm DEF 14A 249971
2 logo_tempest.jpg GRAPHIC 30878
3 ny20036455x2_pc01.jpg GRAPHIC 526605
4 ny20036455x2_pc02.jpg GRAPHIC 406384
  Complete submission text file 0001140361-24-046210.txt   1577720
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35890 | Film No.: 241449190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)